SCHEMBL6094286

SCHEMBL6094286

Nc1cc([O])cc(C(=O)NCc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
PLAU P00749 1/20 0.52
HPGD P15428 2/20 0.51
CA2 P00918 1/20 0.51
ALDH1A1 P00352 2/20 0.51
CFD P00746 1/20 0.51
LMNA P02545 1/20 0.50
RAB9A P51151 1/20 0.50
CYP2C19 P33261 1/20 0.50
CYP2D6 P10635 1/20 0.49
EGFR P00533 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
APOBEC3A P31941 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
HPGDS O60760 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9999560 0.91 HDAC6 (0.60) HDAC2HDAC8HDAC6PLAUHPGD
SCHEMBL6094291 0.85 EGFR (0.59) HDAC2HDAC8HDAC6PLAUHPGD
SCHEMBL6093474 0.85 CFD (0.55) HDAC2HDAC8HDAC6PLAUHPGD
SCHEMBL23474248 0.84 GAA (0.62) HDAC2HDAC8HDAC6PLAUHPGD
SCHEMBL6093479 0.84 HDAC2 (0.53) HDAC2HDAC8HDAC6PLAUHPGD
SCHEMBL2915318 0.82 HDAC6 (0.74) HDAC2HDAC8HDAC6HPGDALDH1A1
SCHEMBL8395188 0.81 HDAC6 (0.69) HDAC2HDAC8HDAC6PLAUHPGD
SCHEMBL23511445 0.80 LMNA (0.68) HDAC8HDAC6CA2ALDH1A1LMNA
SCHEMBL6094430 0.80 SMN1; SMN2 (0.57) HPGDALDH1A1LMNARAB9ACYP2C19
SCHEMBL6737728 0.79 HDAC6 (0.72) HDAC2HDAC8HDAC6HPGDCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US claimed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US claimed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US claimed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US disclosed
US-6870056-B1 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2005-03-22 US disclosed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US disclosed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US disclosed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed